Gene · 53905
Papers1,614
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,614
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oxidative Stress in Parasitic Diseases-Reactive Oxygen Species as Mediators of Interactions between the Host and the Parasites. | Antioxidants (Basel) | 2023 | 38247462 | PubTator, text mining | PubMed |
| Ferroptosis: Emerging Role in Diseases and Potential Implication of Bioactive Compounds. | Int J Mol Sci | 2023 | 38139106 | PubTator, text mining | PubMed |
| Evaluation of patients diagnosed with congenital hypothyroidism by newborn screening between 2011-2019 in Diyarbakir, Turkey. | Medicine (Baltimore) | 2023 | 38134076 | PubTator, text mining | PubMed |
| Results of neonatal screening for congenital hypothyroidism and hyperphenylalaninemia in Zhejiang province from 1999 to 2022. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2023 | 38105685 | PubTator, text mining | PubMed |
| Case report: Neonatal-onset inflammatory bowel disease due to novel compound heterozygous mutations in DUOX2. | Front Genet | 2023 | 38075699 | PubTator, text mining | PubMed |
| Ferroptosis in epithelial ovarian cancer: a burgeoning target with extraordinary therapeutic potential. | Cell Death Discov | 2023 | 38040696 | PubTator, text mining | PubMed |
| The recent advancements of ferroptosis in the diagnosis, treatment and prognosis of ovarian cancer. | Front Genet | 2023 | 38028615 | PubTator, text mining | PubMed |
Genome editing approaches with CRISPR/Cas9: the association of NOX4 expression in breast cancer patients and effectiveness evaluation of different strategies of CRISPR/Cas9 to knockout Nox4 in cancer cells. | BMC Cancer | 2023 | 38012557 | PubTator, text mining | PubMed |
| Reactive Oxygen Species and Strategies for Antioxidant Intervention in Acute Respiratory Distress Syndrome. | Antioxidants (Basel) | 2023 | 38001869 | PubTator, text mining | PubMed |
| XBP1 Modulates the Aging Cardiorenal System by Regulating Oxidative Stress. | Antioxidants (Basel) | 2023 | 38001786 | PubTator, text mining | PubMed |
| Longitudinal dynamics of the tumor hypoxia response: From enzyme activity to biological phenotype. | Sci Adv | 2023 | 37992163 | PubTator, text mining | PubMed |
| Extracellular Mechanisms of Neutrophils in Immune Cell Crosstalk. | Immune Netw | 2023 | 37970234 | PubTator, text mining | PubMed |
| The RAAS Goodfellas in Cardiovascular System. | J Clin Med | 2023 | 37959338 | PubTator, text mining | PubMed |
| Effects and Mechanisms of Non-Thermal Plasma-Mediated ROS and Its Applications in Animal Husbandry and Biomedicine. | Int J Mol Sci | 2023 | 37958872 | PubTator, text mining | PubMed |
| A Metabolic Gene Survey Pinpoints Fucosylation as a Key Pathway Underlying the Suppressive Function of Regulatory T Cells in Cancer. | Cancer Immunol Res | 2023 | 37933083 | PubTator, text mining | PubMed |
| Functionalized Gold Nanoparticles Suppress the Proliferation of Human Lung Alveolar Adenocarcinoma Cells by Deubiquitinating Enzymes Inhibition. | ACS Omega | 2023 | 37929120 | PubTator, text mining | PubMed |
| From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration. | Front Pharmacol | 2023 | 37927596 | PubTator, text mining | PubMed |
| ADRB2 inhibition combined with antioxidant treatment alleviates lung fibrosis by attenuating TGFβ/SMAD signaling in lung fibroblasts. | Cell Death Discov | 2023 | 37923730 | PubTator, text mining | PubMed |
| PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy. | Nat Metab | 2023 | 37903887 | PubTator, text mining | PubMed |
| Environmental Endocrinology: Parabens Hazardous Effects on Hypothalamic-Pituitary-Thyroid Axis. | Int J Mol Sci | 2023 | 37894927 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53905/papers?page=4